Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent?

EuroIntervention 2017;13:e585-e594 published online March 2017 published online e-edition August 2017. DOI: 10.4244/EIJ-D-17-00070

Yohei Sotomi
Yohei Sotomi1, MD; Yoshinobu Onuma2,3, MD, PhD; Yosuke Miyazaki2, MD, PhD; Taku Asano1, MD; Yuki Katagiri1, MD; Erhan Tenekecioglu2, MD; Hans Jonker3, BSc; Jouke Dijkstra4, PhD; Robbert J. de Winter1, MD, PhD; Joanna J. Wykrzykowska1, MD, PhD; Gregg W. Stone5, MD; Jeffrey J. Popma6, MD, PhD; Ken Kozuma7, MD, PhD; Kengo Tanabe8, MD, PhD; Patrick W. Serruys9, MD, PhD; Takeshi Kimura10, MD, PhD
1. Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; 2. Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; 3. Cardialysis, Rotterdam, the Netherlands; 4. LKEB–Division of Image Processing, Department of Radiology

Aims: Immediately after stent/scaffold implantation, quantitative coronary angiography (QCA) in comparison to optical coherence tomography (OCT) more severely underestimates the lumen dia

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

bioresorbable scaffoldsclinical researchoptical coherence tomographyquantitative coronary angiography
Coronary interventionsStents and scaffoldsTools, devices and techniques
Read next article
Prevalence and outcomes of coronary artery perforation during percutaneous coronary intervention

Latest news